Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.

Dawson, N

Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jan 1998 - 37-44 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

1078-0432


Adult
Aged
Aged, 80 and over
Aminoglutethimide--administration & dosage
Androgen Antagonists--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Humans
Male
Middle Aged
Prostatic Neoplasms--drug therapy
Suramin--administration & dosage
Survival Rate